Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Crinecerfont (SSR-125543) is a selective antagonist of corticotropin-releasing factor 1 receptor (CRF1) and can be used in studies about Classic congenital adrenal hyperplasia.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 195.00 | |
2 mg | In stock | $ 293.00 | |
5 mg | In stock | $ 449.00 | |
10 mg | In stock | $ 659.00 | |
25 mg | In stock | $ 987.00 | |
50 mg | In stock | $ 1,390.00 | |
100 mg | In stock | $ 1,880.00 | |
500 mg | In stock | $ 3,780.00 |
Description | Crinecerfont (SSR-125543) is a selective antagonist of corticotropin-releasing factor 1 receptor (CRF1) and can be used in studies about Classic congenital adrenal hyperplasia. |
Synonyms | SSR125543, SSR 125543, SSR-125543, SSR125543A, SSR 125543A, SSR-125543A |
Molecular Weight | 483.04 |
Formula | C27H28ClFN2OS |
CAS No. | 752253-39-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: Soluble
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Crinecerfont 752253-39-7 GPCR/G Protein CRFR SSR125543 SSR 125543 SSR-125543 SSR125543A SSR 125543A SSR-125543A inhibitor inhibit